Evidence map›Paper›PMID 30653445›Full record

ArticleAutophagy2019

A role for stromal autophagy in cancer-associated fibroblast activation.

Sandro Goruppi, Andrea Clocchiatti, G Paolo Dotto

Open access · bronzeAbstract readComment
In one paragraph

Article in Autophagy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Roles of Notch Signaling in the Tumor Microenvironment.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Article
  7. SM22αJournal of experimental & clinical cancer research : CR · 2020
    Article
  8. Article
  9. The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer.Journal of experimental & clinical cancer research : CR · 2019
    Review
  10. The Exosome And Breast Cancer Cell Plasticity.OncoTargets and therapy · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Sandro Goruppia Massachusetts General Hospital , Cutaneous Biology Research Center , Charlestown , MA , USA.ORCID 0000-0002-2976-8983
Andrea Clocchiattia Massachusetts General Hospital , Cutaneous Biology Research Center , Charlestown , MA , USA.
G Paolo Dottoa Massachusetts General Hospital , Cutaneous Biology Research Center , Charlestown , MA , USA.ORCID 0000-0002-1197-8448
Harvard University · USMassachusetts General Hospital · US

Funding

GROWTH DIFFERENTIATION CONTROL IN PRIMARY KERATINOCYTES.R01AR039190 · NIAMS · YALE UNIVERSITY · PI DOTTO, GIAN-PAOLO · 1988 to 2021
$9.5M
Dermal fibroblast/ATF3 control of skin homeostasisR01AR064786 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI DOTTO, GIAN-PAOLO · 2014 to 2018
$1.9M
NIAMS NIH HHS R01 AR039190NIAMS NIH HHS R01 AR064786
6 · The paper itself

Abstract

In the tumor stroma, cancer-associated fibroblasts (CAFs) affect all aspects of tumor evolution. Whereas several programs leading to CAF activation have been elucidated, little is known about the impact of the microenvironment on the turnover of key CAF regulators. RBPJ/CSL is a transcriptional repressor that mediates NOTCH signaling and its down-modulation activates the gene expression program(s) leading to stromal senescence and CAF activation. We overview our evidence that conditions increasing macroautophagy/autophagy, as often found in the stroma of tumors, cause the down-modulation of the RBPJ protein. This event requires the autophagic machinery and is functionally relevant because it is associated with an increase of CAF effector gene expression. The mechanism involves the direct association with the autophagy receptor SQSTM1/p62, which is required for RBPJ down-modulation. As a reflection of increased autophagy in the stroma, both the RBPJ and SQSTM1 proteins are down-modulated in Squamous Cell Carcinoma (SCC) patient-derived CAFs. Increasing RBPJ cellular levels stabilizes SQSTM1 and down-modulates the autophagic process. Our findings identify an autophagy-initiated mechanism for RBPJ down-modulation leading to increased CAF gene expression.

Indexed as

AutophagyCancer-Associated FibroblastsCarcinoma, Squamous CellFibroblastsHumansSignal TransductionTumor MicroenvironmentCAF (cancer-associated fibroblast)CSL/RBP-Jκprotein turnoverSQSTM1/p62tumor stroma

Identifiers

PMID30653445
PMCPMC6526841
OpenAlexW2910076233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.